Cannabis and the Developing Adolescent Brain

被引：11
作者：
Fischer A.S. [1 ]
Tapert S.F. [2 ]
Louie D.L. [1 ]
Schatzberg A.F. [1 ]
Singh M.K. [1 ]
机构：
[1] Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA
[2] Department of Psychiatry, University of California San Diego, San Diego, CA
来源：
Current Treatment Options in Psychiatry | 2020年 / 7卷 / 2期
关键词：
Adolescence; Cannabidiol (CBD); Cannabis; Cannabis use disorder; Delta-9-tetrahydrocannabinol (THC); Neurodevelopment;
D O I：
10.1007/s40501-020-00202-2
中图分类号：
学科分类号：
摘要：
Purpose of review: This review summarizes (1) recent trends in delta-9-tetrahydrocannabionol [THC] and cannabidiol (CBD) content in cannabis products, (2) mechanism of action of THC and CBD and the neurobiological correlates of cannabis use on the developing adolescent brain, (3) effects of cannabis on psychiatric symptoms and daily functioning in youth (i.e., academic performance, cognition, sleep and driving), (4) cannabis products used to relieve or treat medical issues in youth, and (5) available treatments for cannabis use disorder in adolescence. Recent findings: Despite marked increases in THC content and availability of cannabis, there has been a decline in perceived risk and an increase in use of cannabis extract products among youth in the USA. The primary psychiatric symptoms associated with cannabis use in youth are increased risk for addiction, depressive, and psychotic symptoms. Adolescent cannabis exposure also contributes to impaired cognition, sleep, and driving ability. Cannabis alters endocannabinoid system function which plays a central role in modulating the neurodevelopment of reward and stress systems. However, few studies have examined neurobiological mechanisms underlying the psychiatric and functional sequalae of cannabis exposure in youth. To-date, FDA-approved cannabinoid medications are very limited, none of them supporting their use for the treatment of psychiatric symptoms. Behavioral therapies are currently the mainstay of treating cannabis misuse, with no pharmacotherapies currently approved by the FDA for cannabis use disorder in youth. Summary: Here, we summarize the neurobiological, psychiatric, and daily function effects of the most commonly used cannabinoids: delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). Our current understanding of the effects of cannabis on the developing brain and treatments for cannabis misuse in youth remain limited. Future research aimed at examining the neurobiological effects of cannabis, with objective measures of exposure, over the course of pediatric development and in relation to psychiatric symptoms are needed. © 2020, Springer Nature Switzerland AG.
引用
收藏
页码：144 / 161
页数：17
相关论文
共 100 条
[11]  
Wackowski O.A., Sontag J.M., Hammond D., O'Connor R.J., Ohman-Strickland P.A., Strasser A.A., Et al., The impact of e-cigarette warnings, warning themes and inclusion of relative harm statements on young adults’ e-cigarette perceptions and use intentions, Int J Environ Res Public Health, 16, 2, (2019)
[12]  
Hulvershorn L.A., Understanding the child at risk for substance use disorders: Neuroimaging addiction risk, J am Acad Child Adolesc Psychiatry, 58, 7, pp. 663-664, (2019)
[13]  
Prince M.A., Conner B.T., Pearson M.R., Quantifying cannabis: a field study of marijuana quantity estimation, Psychol Addict Behav, 32, 4, pp. 426-433, (2018)
[14]  
Casajuana C., Lopez-Pelayo H., Balcells M.M., Miquel L., Colom J., Gual A., Definitions of risky and problematic cannabis use: a systematic review, Subst Use Misuse, 51, 13, pp. 1760-1770, (2016)
[15]  
(2019)
[16]  
Keeley R.J., Trow J., McDonald R.J., Strain and sex differences in puberty onset and the effects of THC administration on weight gain and brain volumes, Neuroscience., 305, pp. 328-342, (2015)
[17]  
Meyer H.C., Lee F.S., Gee D.G., The role of the endocannabinoid system and genetic variation in adolescent brain development, Neuropsychopharmacology., 43, 1, pp. 21-33, (2018)
[18]  
Volkow N.D., Swanson J.M., Evins A.E., DeLisi L.E., Meier M.H., Gonzalez R., Bloomfield M.A., Curran H.V., Baler R., Effects of cannabis use on human behavior, including cognition, motivation, and psychosis: a review, JAMA Psychiatry, 73, 3, pp. 292-297, (2016)
[19]  
Volkow N.D., Hampson A.J., Baler R.D., Don't Worry, Be happy: endocannabinoids and cannabis at the intersection of stress and reward, Annu Rev Pharmacol Toxicol, 57, pp. 285-308, (2017)
[20]  
Dudok B., Barna L., Ledri M., Szabo S.I., Szabadits E., Pinter B., Et al., Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling, Nat Neurosci, 18, 1, pp. 75-86, (2015)
12345678910